Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer
Cell Biology and Toxicology · 2026
DOI: 10.1007/s10565-026-10147-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2026. Verfasst von Sara Gomes und 6 weiteren Autor:innen. Beteiligte Einrichtung: CBMA - Centre of Molecular and Environmental Biology, Department of Biology, University of Minho, Campus de Gualtar, 4710-054, Braga, Portugal. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Fluorouracil, Gastrointestinal Microbiome, Fatty Acids, Volatile. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Universidade do Minho.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Colorectal cancer (CRC) remains one of the leading causes of cancer-related deaths worldwide, largely due to late-stage diagnosis and limited efficacy of current therapies. 5-Fluorouracil (5-FU) is the standard chemotherapeutic agent used in CRC treatment; however, its effectiveness is often hampered by resistance, toxicity, and suboptimal outcomes in advanced-stage tumors. Recent evidence suggests that gut microbiota-derived short-chain fatty acids (SCFAs) exert anticancer effects and may hold promise as therapeutic adjuvants. In this study, we investigated the potential of a physiologically relevant mixture of SCFAs to enhance the efficacy of 5-FU against CRC. Using a combination of 2D monolayer cultures, 3D models, and the in vivo chicken chorioallantoic membrane (CAM) assay, we demonstrated that SCFAs positively affect the antitumor effects of low-dose 5-FU. SCFAs contributed to the inhibition of CRC cell growth, proliferation, survival, and migration, with an overall increase of the anti-tumour effects observed across the different models. The combined treatment led to a significant reduction in tumour size in the CAM assay, contributing for an improvement of the effects of 5-FU alone. To our knowledge, this is the first report showing that physiologically relevant SCFA combinations can be harnessed to improve the therapeutic index of 5-FU in CRC, in a context-dependent manner. These findings support the development of microbiota-targeted co-adjuvant strategies to optimize CRC chemotherapy, reduce treatment toxicity, and improve patient outcomes, which is important given the clinical interest in microbiome-chemotherapy interactions. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CBMA - Centre of Molecular and Environmental Biology, Department of Biology, University of Minho, Campus de Gualtar, 4710-054, Braga, Portugal.
- IBS - Institute of Science and Innovation for Bio-Sustainability, University of Minho, Braga, Portugal.
- School of Medicine, ICVS - Life and Health Sciences Research Institute, University of Minho, Braga, Portugal.
- ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
- Department of Life Sciences, Brunel University, London, UK.
- REQUIMTE/LAQV, ESS, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
Förderung
- Fundação para a Ciência e a Tecnologia
- Universidade do Minho
Zitieren
APA
Gomes, S., Granja, S., Osório, L. A., Mackay, R. E., Baltazar, F., Silva, E., & Preto, A. (2026). Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10147-6
Vancouver
Gomes S, Granja S, Osório LA, Mackay RE, Baltazar F, Silva E, et al. Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-026-10147-6
BibTeX
@article{Gomes2026,
author = {Gomes, Sara and Granja, Sara and Osório, Luana A and Mackay, Ruth E and Baltazar, Fátima and Silva, Elisabete and Preto, Ana},
title = {Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer},
journal = {Cell Biology and Toxicology},
year = {2026},
doi = {10.1007/s10565-026-10147-6}
}
EUVIMED